{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:15:35Z","timestamp":1785525335806,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010346","name":"University of Colorado Denver","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics Inc","doi-asserted-by":"publisher","award":["QUITTIN14Q10"],"award-info":[{"award-number":["QUITTIN14Q10"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics Inc","doi-asserted-by":"publisher","award":["SAWICK14PE1"],"award-info":[{"award-number":["SAWICK14PE1"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics Inc","doi-asserted-by":"publisher","award":["RIEKER15PE0"],"award-info":[{"award-number":["RIEKER15PE0"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics Inc","doi-asserted-by":"publisher","award":["BARRIERS16PE0"],"award-info":[{"award-number":["BARRIERS16PE0"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006458","name":"Children's Hospital of Philadelphia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006475","name":"Bergens Forskningsstiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011531","name":"University of Alabama","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jcf.2024.10.011","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T23:13:20Z","timestamp":1730416400000},"page":"326-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Supporting adherence to the cystic fibrosis regimen: Development and validation of The Daily Care Check-In (DCC)"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6892-3512","authenticated-orcid":false,"given":"Kristin A.","family":"Riekert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3855-770X","authenticated-orcid":false,"given":"Christine","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Eckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3495-970X","authenticated-orcid":false,"given":"Angela","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4139-6983","authenticated-orcid":false,"given":"Alexandra L.","family":"Quittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcf.2024.10.011_bib0001","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.12.009","article-title":"Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes","volume":"12","author":"Sawicki","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2024.10.011_bib0002","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1378\/chest.13-1926","article-title":"Pulmonary medication adherence and health-care use in cystic fibrosis","volume":"146","author":"Quittner","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jcf.2024.10.011_bib0003","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2011.03.005","article-title":"Longitudinal association between medication adherence and lung health in people with cystic fibrosis","volume":"10","author":"Eakin","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2024.10.011_bib0004","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/thoraxjnl-2020-215556","article-title":"Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study","volume":"76","author":"Mitchell","year":"2021","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.jcf.2024.10.011_bib0005","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jcf.2023.03.006","article-title":"Association between nebuliser therapies adherence and visit-to-visit variability of FEV1 in patients with cystic fibrosis","volume":"22","author":"Drummond","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"173","key":"10.1016\/j.jcf.2024.10.011_bib0006","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0060-2024","article-title":"Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review","volume":"33","author":"Hansen","year":"2024","journal-title":"European respiratory review"},{"issue":"2","key":"10.1016\/j.jcf.2024.10.011_bib0007","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.09-3074","article-title":"Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers","volume":"140","author":"Daniels","year":"2011","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jcf.2024.10.011_bib0008","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.chest.2021.06.039","article-title":"Real-World Adherence Among Adults with Cystic Fibrosis Is Low: a Retrospective Analysis of the CFHealthHub Digital Learning Health System","volume":"160","author":"Hoo","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2024.10.011_bib0009","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1016\/S1569-1993(23)01410-8","article-title":"Measuring adherence to chronic therapies over 2 years of treatment with elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis\u2014The RECOVER Study","volume":"22","author":"Sutton","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2024.10.011_bib0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ppul.23017","article-title":"Motivating adherence among adolescents with cystic fibrosis: youth and parent perspectives","volume":"50","author":"Sawicki","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.jcf.2024.10.011_bib0011","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcf.2010.08.016","article-title":"Perceptions of barriers and facilitators: self-management decisions by older adolescents and adults with CF","volume":"9","author":"George","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2024.10.011_bib0012","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bjhp.12357","article-title":"Adherence to medication in adults with Cystic Fibrosis: an investigation using objective adherence data and the Theoretical Domains Framework","volume":"24","author":"Arden","year":"2019","journal-title":"Br J Health Psychol"},{"issue":"1","key":"10.1016\/j.jcf.2024.10.011_bib0013","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11096-014-0043-6","article-title":"Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study","volume":"37","author":"Hogan","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jcf.2024.10.011_bib0014","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/PPA.S25308","article-title":"Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents","volume":"5","author":"Bregnballe","year":"2011","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jcf.2024.10.011_bib0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2147\/PPA.S389792","article-title":"A Participatory Approach Involving Patients with Cystic Fibrosis and Healthcare Professionals for the Co-Design of an Adherence-Enhancing Intervention Toolkit","volume":"17","author":"Viprey","year":"2023","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"10.1016\/j.jcf.2024.10.011_bib0016","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jcf.2017.05.001","article-title":"Development and validation of CF-Medication Beliefs Questionnaire: a mixed-methods approach","volume":"16","author":"Eakin","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.10.011_bib0017","unstructured":"Riekert, K.A. (2009-2014) Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience (BALANCE) ClinicalTrials.gov ID NCT01013896. https:\/\/www.clinicaltrials.gov\/study\/NCT01013896?cond=NCT01013896&rank=1."},{"issue":"6","key":"10.1016\/j.jcf.2024.10.011_bib0018","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jcf.2019.05.004","article-title":"Clustered randomized controlled trial of a clinic-based problem-solving intervention to improve adherence in adolescents with cystic fibrosis","volume":"18","author":"Quittner","year":"2019","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2024.10.011_bib0019","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.pec.2020.02.025","article-title":"Misunderstandings, misperceptions, and missed opportunities: perspectives on adherence barriers from people with CF, caregivers, and CF team members","volume":"103","author":"Eaton","year":"2020","journal-title":"Patient Educ Couns"},{"issue":"4","key":"10.1016\/j.jcf.2024.10.011_bib0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s10880-018-9598-z","article-title":"Identifying Factors that Facilitate Treatment Adherence in Cystic Fibrosis: qualitative Analyses of Interviews with Parents and Adolescents","volume":"26","author":"Nicolais","year":"2019","journal-title":"J Clin Psychol Med Settings"},{"issue":"7","key":"10.1016\/j.jcf.2024.10.011_bib0021","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1\u20133","key":"10.1016\/j.jcf.2024.10.011_bib0022","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","article-title":"The PHQ-8 as a measure of current depression in the general population","volume":"114","author":"Kroenke","year":"2009","journal-title":"J Affect Disord"},{"issue":"10","key":"10.1016\/j.jcf.2024.10.011_bib0023","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.jcf.2024.10.011_bib0024","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1076\/chin.6.3.235.3152","article-title":"Behavior rating inventory of executive function","volume":"6","author":"Baron","year":"2000","journal-title":"Child neuropsychology: a journal on normal and abnormal development in childhood and adolescence"},{"issue":"4","key":"10.1016\/j.jcf.2024.10.011_bib0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1076\/chin.8.4.249.13513","article-title":"Confirmatory factor analysis of the Behavior Rating Inventory of Executive Function (BRIEF) in a clinical sample","volume":"8","author":"Gioia","year":"2002","journal-title":"Child neuropsychology"},{"key":"10.1016\/j.jcf.2024.10.011_bib0026","doi-asserted-by":"crossref","unstructured":"Roth, R.M., Isquith, P.K., & Gioia, G.A. (2005). Behavioral rating inventory of executive function\u2014adult version. Lutz, FL: Psychological Assessment Resources, Inc.","DOI":"10.1037\/t86244-000"},{"issue":"7","key":"10.1016\/j.jcf.2024.10.011_bib0027","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s11136-011-0036-z","article-title":"Psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national sample","volume":"21","author":"Quittner","year":"2012","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jcf.2024.10.011_bib0028","unstructured":"SAS Institute Inc. 2017. SAS\u00ae 9.4 global statements: reference. cary, NC: SAS Institute Inc."},{"key":"10.1016\/j.jcf.2024.10.011_bib0029","unstructured":"RStudio Team (2020). RStudio: integrated development for r. RStudio, PBC, Boston, MA. URL http:\/\/www.rstudio.com\/."},{"issue":"1","key":"10.1016\/j.jcf.2024.10.011_bib0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jcf.2014.10.003","article-title":"Opportunities for cystic fibrosis care teams to support treatment adherence","volume":"14","author":"Riekert","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2024.10.011_bib0031","first-page":"1","article-title":"I think most people feel like healthcare professionals tell them to take their treatments and judge them for not taking them\": reflexive thematic analysis of the views of adults with cystic fibrosis on how treatment adherence is discussed in healthcare","author":"Dawson","year":"2023","journal-title":"Psychol Health"},{"issue":"6","key":"10.1016\/j.jcf.2024.10.011_bib0032","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcf.2022.05.005","article-title":"Research letter: the impact of elexacaftor\/tezacaftor\/ivacaftor on adherence to nebulized maintenance therapies in people with cystic fibrosis","volume":"21","author":"Song","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2024.10.011_bib0033","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chest.2023.10.043","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor: multidimensional assessment of neuropsychological side effects and physical and mental health outcomes in adolescents and adults","volume":"165","author":"Graziano","year":"2024","journal-title":"Chest"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324018046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199324018046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:37:23Z","timestamp":1777333043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199324018046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1569199324018046"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.10.011","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supporting adherence to the cystic fibrosis regimen: Development and validation of The Daily Care Check-In (DCC)","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}